Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation ; volume:18 ; number:1 ; day:21 ; month:1 ; year:2020 ; pages:1-13 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (21.1.2020), 1-13, 12.2020
- Urheber
-
Misawa, Kiyoshi
Mima, Masato
Satoshi, Yamada
Imai, Atsushi
Mochizuki, Daiki
Ishikawa, Ryuji
Kita, Junya
Yamaguchi, Yuki
Endo, Shiori
Misawa, Yuki
Mineta, Hiroyuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-020-02214-1
- URN
-
urn:nbn:de:101:1-2020042222095315970164
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Misawa, Kiyoshi
- Mima, Masato
- Satoshi, Yamada
- Imai, Atsushi
- Mochizuki, Daiki
- Ishikawa, Ryuji
- Kita, Junya
- Yamaguchi, Yuki
- Endo, Shiori
- Misawa, Yuki
- Mineta, Hiroyuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Epigenetic Inactivation of Cell-Cycle Regulators in Lung Cancer
Epigenetic inactivation of the MIR129-2 in hematological malignancies
DNA sequence and chromatin modifiers cooperate to confer epigenetic bistability at imprinting control regions
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Epigenetic inactivation of the NORE1gene correlates with malignant progression of colorectal tumors
Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
Power to confer Knighthood.
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Epigenetic Inactivation of Cell-Cycle Regulators in Lung Cancer
Epigenetic inactivation of the MIR129-2 in hematological malignancies
DNA sequence and chromatin modifiers cooperate to confer epigenetic bistability at imprinting control regions
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Epigenetic inactivation of the NORE1gene correlates with malignant progression of colorectal tumors
Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients
Power to confer Knighthood.
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Epigenetic inactivation of ST6GAL1 in human bladder cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Epigenetic Inactivation of Cell-Cycle Regulators in Lung Cancer
Epigenetic inactivation of the MIR129-2 in hematological malignancies
DNA sequence and chromatin modifiers cooperate to confer epigenetic bistability at imprinting control regions
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Epigenetic inactivation of the NORE1gene correlates with malignant progression of colorectal tumors
Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation
Parkin gene mutations are not common, but its epigenetic inactivation is a frequent event and predicts poor survival in advanced breast cancer patients